Bone health therapy developer Juvent joins Louisville aging care accelerator

PALM BEACH GARDENS, Fla. – Juvent, a Florida-based medical technology company with a leading focus in bone health, is now an active alliance partner of the International Center for Long Term Care Innovation, also known as InnovateLTC in downtown Louisville.

Innovate LTC is the acclaimed industry accelerator building the premier facility for showcasing aging care products and services from all over the world. The center has office space at University of Louisville’s Nucleus site, in downtown Louisville, and will have a major presence in a new 160,000-s.f. research facility expected to be finished in late 2013.

Juvent will participate in InnovateLTC’s Consumer Experience Center, which will foster interdisplinary interaction and be a place for designing, pitching and testing products, services and technologies for the 50+ market. The ecosystem enables participation for consumer groups, healthcare providers, academics, and emerging companies to create and innovate together.

The company recently exhibited its Juvent Dynamic Motion Therapy® platform  at the National Osteoporosis Foundation’s (NOF) Interdisciplinary Symposium on Osteoporosis 2013 (ISO13) April 18-21 in Chicago. Its gentle vibrating platform, the patented Juvent 1000N, offers a non-drug treatment, an exercise methodology, specifically designed for bone health.

The Juvent technology is based on 20 years of academic and clinical research, backed by more than 100 published articles, and 34 in peer-reviewed journals. New research continues at St. Jude Children’s Hospital; Hebrew SeniorLife, affiliated with Harvard Medical School, and Children’s Hospital of Philadelphia.

Juvent also announced its recent appointment to the Corporate Advisory Roundtable of NOF.

“We are honored to be joining the conversation at the roundtable level, looking to generate innovation for the improvement of bone health, circulation and well-being in combatting the effects of osteoporosis,” said Rush Simonson, CEO of Juvent, which is one of only 19 members to have been selected for 2013.

“This symposium opportunity represents the first time we have exhibited at an NOF event as a Corporate Roundtable member, to explore the medical and clinical perspectives in medicine today,” Simonson said. “We are pleased to have forged a relationship with an organization that offers excellent support groups for patients and their families.”

Juvent has assembled an experienced management team of medical technology leaders and bone health and anti-aging experts. Juvent’s 20 years of research and development, 20-plus patents and more than $20 million invested in the company’s vision has resulted in groundbreaking research and technologies to combat the effects of aging and poor bone health. Its patented “Dynamic Motion Therapy®” device is the first to meet OSHA guidelines, safely using only 0.3g and 32 to 37 Hz mechanical signals, and has proven to be effective for exercise. Patented “Smart Technology” automatically calibrates treatment to a patient’s body weight and mass.

The Juvent 1000 is available in the U.S. and Taiwan, and soon in Canada, Europe, Australia and New Zealand. In the U.S., the Juvent 1000 device is FDA cleared as a Class I exercise device and the company plans to seek expanded FDA approval for the treatment of osteoporosis and a renewal of its CE approval for osteoporosis.